Product Information
RAMELTEON 8 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.6898 per EA under NDC 00591219101. Its NADAC has been published 354 times since Sep 18, 2019.
Strength
8 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591219101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RAMELTEONApproval Type
Generic (ANDA)
FDA Application
ANDA091610On Market Since
7/22/2019
Pharmacological Classes
Price Statistics
The NADAC for RAMELTEON 8 MG TABLET has been published 354 times since Sep 18, 2019, and over the history we have for it it has declined 77.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6898 per EA |
|---|---|
| All-time high | $3.5757 (Mar 11, 2020) |
| All-time low | $0.5491 (Nov 20, 2024) |
| 52-week high | $0.8071 |
| 52-week low | $0.6898 |
| Median price | $1.0336 |
| Average price | $1.5417 |
| Largest weekly change | +50.1% (Aug 21, 2024) |
| Weeks tracked | 354 |
| Tracking since | Sep 18, 2019 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RAMELTEON 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RAMELTEON 8 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.6898 per EA (NDC 00591219101), effective Jun 24, 2026.
How has the price of RAMELTEON 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for RAMELTEON 8 MG TABLET has declined 77.2%. It has been tracked across 354 weekly CMS publications since Sep 18, 2019.
What are the highest and lowest recorded NADAC prices for RAMELTEON 8 MG TABLET?
Since Sep 18, 2019, the NADAC for RAMELTEON 8 MG TABLET has ranged from a low of $0.5491 (Nov 20, 2024) to a high of $3.5757 (Mar 11, 2020), with a median of $1.0336 per EA.
Are there cheaper alternatives to RAMELTEON 8 MG TABLET?
12 NADAC-published products share the same active ingredient, strength, and dosage form as RAMELTEON 8 MG TABLET, but none are currently priced below it.
Who manufactures RAMELTEON 8 MG TABLET?
RAMELTEON 8 MG TABLET (NDC 00591219101) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification